Part 1/7:
An Overview of AVXL and Cassava: A Market Analysis
In recent discussions regarding biotechnology stocks, two names have emerged prominently: Anavex Life Sciences (AVXL) and Cassava Sciences (SAVA). Both companies are exploring treatment options for Alzheimer's disease, a market rife with potential but equally fraught with skepticism due to past performance and the complexities of drug development.